Xerostomia.
Conditions
Interventions
Intervention 1: Intervention group: In the case group, in addition to massage therapy training, pilocarpine hydrochloride mouthwash will be distributed, which will gargle 30 drops for 2 minutes four t
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Head and neck cancers. Topical laryngeal cancer, hypopharyngeal cancer and nasopharyngeal cancer Under conventional radiation therapy with doses greater than 50 g Satisfaction to participate in the study
Exclusion criteria
Exclusion criteria: Changes in the patient's treatment protocol or process of receiving radiation therapy Lack of patient cooperation in the study process Taking any medication that reduces salivation, physical systemic diseases such as Sjogren's syndrome, diabetes, Behcet's disease, hypertension and hyperthyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salivation rate. Timepoint: Two weeks before the first (basic) radiotherapy session, the first day of radiation therapy and two and four weeks after radiation therapy. Method of measurement: For this purpose, the spitting method will be used in which patients refrain from drinking or eating anything for 90 minutes before sampling. Then, for 5 minutes, people will be asked to empty their saliva into a calibrated test tube once or twice a minute. The amount of saliva (ml in 5 minutes) will be calculated and recorded. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParia Motahari
Tabriz University of Medical Sciences
Outcome results
None listed